keyword
https://read.qxmd.com/read/38630387/neuroradiological-features-of-patients-with-bilateral-macronodular-adrenocortical-disease-and-meningiomas-associated-or-not-with-genetic-variants-of-armc5-a-case-series
#21
JOURNAL ARTICLE
Arthur Araújo Massoud Salame, Helaine Laiz Silva Charchar, José Paulo de Oliveira Dourado, Berenice Mendonca, Guilherme Asmar Alencar, Leonardo José Tadeu de Araújo, Paula Ricci Arantes, Nicollas Nunes Rabelo, Eberval Gadelha Figueiredo, Maria Candida Barisson Villares Fragoso
INTRODUCTION: Meningiomas are the most common primary brain and central nervous system tumors, accounting for approximately 40% of these tumors. The most important exams for the radiological study of meningiomas are computed tomography (CT) and magnetic resonance imaging (MRI). We aimed to analyze the radiological features of patients with meningioma related to the simultaneous presence of bilateral macronodular adrenocortical disease (BMAD), with or without pathogenic variants of ARMC5...
April 17, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38630386/improved-outcomes-for-triple-negative-breast-cancer-brain-metastases-patients-after-stereotactic-radiosurgery-and-new-systemic-approaches
#22
JOURNAL ARTICLE
Elad Mashiach, Juan Diego Alzate, Fernando De Nigris Vasconcellos, Sylvia Adams, Brandon Santhumayor, Ying Meng, Zane Schnurman, Bernadine R Donahue, Kenneth Bernstein, Cordelia Orillac, Rishitha Bollam, Maryann J Kwa, Marleen Meyers, Ruth Oratz, Yelena Novik, Joshua S Silverman, David H Harter, John G Golfinos, Douglas Kondziolka
PURPOSE: Although ongoing studies are assessing the efficacy of new systemic therapies for patients with triple negative breast cancer (TNBC), the overwhelming majority have excluded patients with brain metastases (BM). Therefore, we aim to characterize systemic therapies and outcomes in a cohort of patients with TNBC and BM managed with stereotactic radiosurgery (SRS) and delineate predictors of increased survival. METHODS: We used our prospective patient registry to evaluate data from 2012 to 2023...
April 17, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38630385/exploring-management-and-outcomes-of-elderly-patients-with-glioblastoma-using-data-from-two-randomised-trials-geino1401-ex-tem
#23
JOURNAL ARTICLE
Lucy Gately, C Mesía, J M Sepúlveda, S Del Barco, E Pineda, R Gironés, J Fuster, M Dumas, S Gill, L M Navarro, A Herrero, A Dowling, R de Las Peñas, M A Vaz, M Alonso, Z Lwin, R Harrup, S Peralta, A Long, P Perez-Segura, E Ahern, C O Garate, M Wong, R Campbell, K Cuff, R Jennens, O Gallego, C Underhill, M Martinez-Garcia, M Covela, A Cooper, S Brown, M Rosenthal, J Torres, I M Collins, P Gibbs, C Balana
PURPOSE: The impact of age on optimal management of glioblastoma remains unclear. A recent combined analysis of two randomised trials, GEINO14-01 and EX-TEM, found no benefit from extending post-radiation temozolomide in newly diagnosed glioblastoma. Here, we explore the impact of age. METHODS: Relevant intergroup statistics were used to identify differences in tumour, treatment and outcome characteristics based on age with elderly patients (EP) defined as age 65 years and over...
April 17, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38630384/rebound-growth-of-braf-mutant-pediatric-glioma-cells-after-mapki-withdrawal-is-associated-with-mapk-reactivation-and-secretion-of-microglia-recruiting-cytokines
#24
JOURNAL ARTICLE
Daniela Kocher, Lei Cao, Romain Guiho, Melanie Langhammer, Yun-Lu Lai, Pauline Becker, Hiba Hamdi, Dennis Friedel, Florian Selt, David Vonhören, Julia Zaman, Gintvile Valinciute, Sonja Herter, Daniel Picard, Johanna Rettenmeier, Kendra K Maass, Kristian W Pajtler, Marc Remke, Andreas von Deimling, Stefan Pusch, Stefan M Pfister, Ina Oehme, David T W Jones, Sebastian Halbach, Tilman Brummer, Juan Pedro Martinez-Barbera, Olaf Witt, Till Milde, Romain Sigaud
INTRODUCTION: Patients with pediatric low-grade gliomas (pLGGs), the most common primary brain tumors in children, can often benefit from MAPK inhibitor (MAPKi) treatment. However, rapid tumor regrowth, also referred to as rebound growth, may occur once treatment is stopped, constituting a significant clinical challenge. METHODS: Four patient-derived pediatric glioma models were investigated to model rebound growth in vitro based on viable cell counts in response to MAPKi treatment and withdrawal...
April 17, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38630267/bibliometric-analysis-of-emerging-trends-and-research-foci-in-brainstem-tumor-field-over-30%C3%A2-years-1992-2023
#25
JOURNAL ARTICLE
Yibo Geng, Luyang Xie, Jinping Li, Yang Wang, Xiong Li
PURPOSE: Over the past several decades, numerous articles have been published on brainstem tumors. However, there has been limited bibliometric analysis in this field. Therefore, we conducted a bibliometric analysis to elucidate the evolution and current status of brainstem tumor research. METHODS: We retrieved 5525 studies published in English between 1992 and 2023 from the Web of Science Core Collection database. We employed bibliometric tools and VOSviewer to conduct the analysis...
April 17, 2024: Child's Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery
https://read.qxmd.com/read/38628335/malignant-peripheral-nerve-sheath-tumor-of-the-femoral-nerve-imaging-findings-and-correlation-with-histopathology
#26
Puneeth Kumar, Khaled Abdelrahman, Sujit Maheshwari, Amit Kumar Dey
Malignant peripheral nerve sheath tumors (MPNST) are rare and aggressive soft tissue sarcomas. MPNST diagnosis is made based on biopsy, but distinct features are present on ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI). We present a case of a 24-year-old man presenting with abdominal pain and lower-extremity weakness found to have a large MPNST originating from the left femoral nerve and describe findings on imaging and their histopathologic correlation.
2024: Proceedings of the Baylor University Medical Center
https://read.qxmd.com/read/38628133/very-long-term-outcomes-of-pediatric-patients-treated-for-optic-pathway-gliomas-a-longitudinal-cohort-study
#27
EDITORIAL
Roger J Packer
No abstract text is available yet for this article.
April 17, 2024: Neuro-oncology
https://read.qxmd.com/read/38627876/summary-of-key-points-of-the-response-assessment-in-neuro-oncology-rano-2-0
#28
EDITORIAL
Sang Eun Won, Chong Hyun Suh, Sinae Kim, Hyo Jung Park, Kyung Won Kim
No abstract text is available yet for this article.
April 11, 2024: Korean Journal of Radiology: Official Journal of the Korean Radiological Society
https://read.qxmd.com/read/38621711/feasibility-and-safety-of-bridging-antiplatelet-therapy-with-cangrelor-in-neuro-oncology-a-preliminary-experience
#29
JOURNAL ARTICLE
Giacomo Bertolini, Laura Belli, Stefania Mazza, Pietro Tito Ugolotti, Iacopo Tadonio, Patrizia Ceccarelli, Sandra Rossi, Salvatore Ippolito
Antiplatelet therapy is mandatory for prevention of thrombotic events in patients with a recent history of acute coronary syndromes and/or percutaneous coronary interventions. However, if an urgent surgery is required during antiplatelet therapy, a compromise between the ischemic/thrombotic and hemorrhagic risk has to be reached. Different bridging schemes are reported in the literature, but there is no clear consensus on the optimal treatment strategy in terms of efficacy and safety. Although some indications about the perioperative management of antiplatelet therapy regarding specific surgical specializations are available, balancing the thrombotic and hemorrhagic risk on an individual basis, no evidence referring to neurosurgical or neuro-oncologic procedures is reported...
April 15, 2024: Journal of Neurological Surgery. Part A, Central European Neurosurgery
https://read.qxmd.com/read/38619777/comparative-analysis-of-bevacizumab-and-litt-for-treating-radiation-necrosis-in-previously-radiated-cns-neoplasms-a-systematic-review-and-meta-analysis
#30
REVIEW
Neslihan Nisa Gecici, Muhammet Enes Gurses, Brandon Kaye, Natasha L Frontera Jimenez, Chandler Berke, Elif Gökalp, Victor M Lu, Michael E Ivan, Ricardo J Komotar, Ashish H Shah
PURPOSE: Radiation necrosis (RN) is a local inflammatory reaction that arises in response to radiation injury and may cause significant morbidity. This study aims to evaluate and compare the efficacy of bevacizumab and laser interstitial thermal therapy (LITT) in treating RN in patients with previously radiated central nervous system (CNS) neoplasms. METHODS: PubMed, Cochrane, Scopus, and EMBASE databases were screened. Studies of patients with radiation necrosis from primary or secondary brain tumors were included...
April 15, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38616896/single-nucleus-expression-characterization-of-non-enhancing-region-of-recurrent-high-grade-glioma
#31
JOURNAL ARTICLE
Kunal S Patel, Kaleab K Tessema, Riki Kawaguchi, Lindsey Dudley, Alvaro G Alvarado, Sree Deepthi Muthukrishnan, Travis Perryman, Akifumi Hagiwara, Vivek Swarup, Linda M Liau, Anthony C Wang, William Yong, Daniel H Geschwind, Ichiro Nakano, Steven A Goldman, Richard G Everson, Benjamin M Ellingson, Harley I Kornblum
BACKGROUND: Non-enhancing (NE) infiltrating tumor cells beyond the contrast-enhancing (CE) bulk of tumor are potential propagators of recurrence after gross total resection of high-grade glioma. METHODS: We leveraged single-nucleus RNA sequencing on 15 specimens from recurrent high-grade gliomas ( n  = 5) to compare prospectively identified biopsy specimens acquired from CE and NE regions. Additionally, 24 CE and 22 NE biopsies had immunohistochemical staining to validate RNA findings...
2024: Neuro-oncology advances
https://read.qxmd.com/read/38616895/potential-roles-for-efferocytosis-in-glioblastoma-immune-evasion
#32
JOURNAL ARTICLE
Ian A J Lorimer
Glioblastoma is an aggressive and incurable brain cancer. This cancer establishes both local and systemic immunosuppression that creates a major obstacle to effective immunotherapies. Many studies point to tumor-resident myeloid cells (primarily microglia and macrophages) as key mediators of this immunosuppression. Myeloid cells exhibit a high level of plasticity with respect to their phenotype and are capable of both stimulating and repressing immune responses. How glioblastomas recruit myeloid cells and exploit them to avoid the immune system is an active area of research...
2024: Neuro-oncology advances
https://read.qxmd.com/read/38608813/intraventricular-glioma-in-pediatric-patients-a-systematic-review-of-demographics-clinical-characteristics-and-outcomes
#33
REVIEW
Gina Watanabe, Andie Conching, Lane Fry, Dillon Putzler, Mohammad Faizan Khan, Mohammad Ammar Haider, Ali S Haider, Gianluca Ferini, Freddie Yamel Rodriguez-Beato, Mayur Sharma, Giuseppe E Umana, Paolo Palmisciano
OBJECTIVE: We conducted a systematic review on pediatric intraventricular gliomas to survey the patient population, tumor characteristics, management, and outcomes. METHODS: PubMed, Scopus, Web-of-Science, and Cochrane were searched using PRISMA guidelines to include studies reporting pediatric patients with intraventricular gliomas. RESULTS: A total of 30 studies with 317 patients were included. Most patients were male (54%), diagnosed at a mean age of 8 years (0...
April 10, 2024: World Neurosurgery
https://read.qxmd.com/read/38608213/systematic-review-of-cerebrospinal-fluid-biomarker-discovery-in-neuro-oncology-a-roadmap-to-standardization-and-clinical-application
#34
REVIEW
Nicholas Mikolajewicz, Patricia P Yee, Debarati Bhanja, Mara Trifoi, Alexandra M Miller, Philippe Metellus, Stephen J Bagley, Leonora Balaj, Leonardo J M de Macedo Filho, Brad E Zacharia, Dawit Aregawi, Michael Glantz, Michael Weller, Manmeet S Ahluwalia, Thomas Kislinger, Alireza Mansouri
Effective diagnosis, prognostication, and management of CNS malignancies traditionally involves invasive brain biopsies that pose significant risk to the patient. Sampling and molecular profiling of cerebrospinal fluid (CSF) is a safer, rapid, and noninvasive alternative that offers a snapshot of the intracranial milieu while overcoming the challenge of sampling error that plagues conventional brain biopsy. Although numerous biomarkers have been identified, translational challenges remain, and standardization of protocols is necessary...
April 12, 2024: Journal of Clinical Oncology
https://read.qxmd.com/read/38607967/nf1-mutation-driven-neuronal-hyperexcitability-sets-a-threshold-for-tumorigenesis-and-therapeutic-targeting-of-murine-optic-glioma
#35
JOURNAL ARTICLE
Corina Anastasaki, Jit Chatterjee, Joshua P Koleske, Yunqing Gao, Stephanie L Bozeman, Chloe M Kernan, Lara I Marco Y Marquez, Ji-Kang Chen, Caitlin E Kelly, Connor J Blair, Dennis J Dietzen, Robert A Kesterson, David H Gutmann
BACKGROUND: With the recognition that noncancerous cells function as critical regulators of brain tumor growth, we recently demonstrated that neurons drive low-grade glioma initiation and progression. Using mouse models of neurofibromatosis type 1 (NF1)-associated optic pathway glioma (OPG), we showed that Nf1 mutation induces neuronal hyperexcitability and midkine expression, which activates an immune axis to support tumor growth, such that high-dose lamotrigine treatment reduces Nf1-OPG proliferation...
April 12, 2024: Neuro-oncology
https://read.qxmd.com/read/38607550/pediatric-hemispheric-cerebellar-low-grade-gliomas-clinical-approach-diagnosis-and-management-challenges-experience-at-a-tertiary-care-children-s-hospital
#36
REVIEW
Santiago Ezequiel Cicutti, Ramiro José Del Río, Adrian Cáceres, Javier Danilo Gonzalez Ramos
PURPOSE: This study aims to provide an exhaustive analysis of pediatric low-grade gliomas (pLGGs) in the cerebellar hemispheres, focusing on incidence, clinical characteristics, surgical outcomes, and prognosis. It seeks to enhance understanding and management of pLGGs in the pediatric population. METHODS: We conducted an observational, descriptive, retrospective, and cross-sectional study at a pediatric hospital, reviewing medical records of 30 patients with cerebellar hemispheric pLGGs treated from December 2014 to January 2023...
April 12, 2024: Child's Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery
https://read.qxmd.com/read/38605644/adult-brain-tumour-research-in-2024-status-challenges-and-recommendations
#37
REVIEW
Karin Purshouse, Helen J Bulbeck, Alasdair G Rooney, Karen E Noble, Ross D Carruthers, Gerard Thompson, Petra Hamerlik, Christina Yap, Kathreena M Kurian, Sarah J Jefferies, Juanita S Lopez, Michael D Jenkinson, C Oliver Hanemann, Lucy F Stead
In 2015, a groundswell of brain tumour patient, carer and charity activism compelled the UK Minister for Life Sciences to form a brain tumour research task and finish group. This resulted, in 2018, with the UK government pledging £20m of funding, to be paralleled with £25m from Cancer Research UK, specifically for neuro-oncology research over the subsequent 5 years. Herein, we review if and how the adult brain tumour research landscape in the United Kingdom has changed over that time and what challenges and bottlenecks remain...
April 2024: Neuropathology and Applied Neurobiology
https://read.qxmd.com/read/38604084/letter-chat-gpt-on-brain-tumors-an-examination-of-artificial-intelligence-machine-learning-s-ability-to-provide-diagnoses-and-treatment-plans-for-example-neuro-oncology-cases
#38
EDITORIAL
Francisco Zarra, Dhruv Nihal Gandhi, Aakriti Karki, Bipin Chaurasia
No abstract text is available yet for this article.
April 2, 2024: Clinical Neurology and Neurosurgery
https://read.qxmd.com/read/38599377/the-socioeconomic-distressed-communities-index-predicts-90-day-mortality-among-intracranial-tumor-patients
#39
JOURNAL ARTICLE
Sachiv Chakravarti, Cathleen C Kuo, Atharv Oak, Sruthi Ranganathan, Adrian E Jimenez, Foad Kazemi, Max A Saint-Germain, Gary Gallia, Jordina Rincon-Torroella, Christopher Jackson, Chetan Bettegowda, Debraj Mukherjee
BACKGROUND: Socioeconomic status (SES) is a major determinant of quality of life and outcomes. However, SES remains difficult to measure comprehensively. Distress communities index (DCI), a composite of seven socioeconomic factors, has been increasingly recognized for its correlation with poor outcomes. OBJECTIVE: To determine the predictive value of DCI on outcomes following intracranial tumor surgery. METHODS: A single institution, retrospective review was conducted to identify adult intracranial tumor patients undergoing resection (2016-2021)...
April 8, 2024: World Neurosurgery
https://read.qxmd.com/read/38598668/liquid-biopsy-for-improving-diagnosis-and-monitoring-of-cns-lymphomas-a-rano-review
#40
JOURNAL ARTICLE
Lakshmi Nayak, Chetan Bettegowda, Florian Scherer, Norbert Galldiks, Manmeet Ahluwalia, Alexander Baraniskin, Louisa von Baumgarten, Jacoline E C Bromberg, Andrés J M Ferreri, Christian Grommes, Khê Hoang-Xuan, Julia Kühn, James L Rubenstein, Roberta Rudà, Michael Weller, Susan M Chang, Martin J van den Bent, Patrick Y Wen, Riccardo Soffietti
BACKGROUND: The utility of liquid biopsies is well documented in several extracranial and intracranial (brain/leptomeningeal metastases, gliomas) tumors. METHODS: The RANO (Response Assessment in Neuro-Oncology) group has set up a multidisciplinary Task Force to critically review the role of blood and CSF-liquid biopsy in central nervous system lymphomas, with a main focus on primary central nervous system lymphomas (PCNSL). RESULTS: Several clinical applications are suggested: diagnosis of PCNSL in critical settings (elderly or frail patients, deep locations, steroids responsiveness), definition of minimal residual disease, early indication of tumor response or relapse following treatments and prediction of outcome...
April 10, 2024: Neuro-oncology
keyword
keyword
1438
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.